Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems

Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia

(2015) Yasufumi Matsumura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis

(2014) Hsih-Yeh Tsai et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort

(2014) R. Leistner et al.   INFECTION

The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum  -lactamase-producing Escherichia coli

(2014) S. H. Park et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)

(2013) Cheryl Li-Ling Lim et al.   BMC INFECTIOUS DISEASES

Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6-Year Period

(2013) Cheol-In Kang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Clinical Outcomes with Ertapenem as a First-Line Treatment Option of Infections Caused by Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria

(2012) Jeffrey J Fong et al.   ANNALS OF PHARMACOTHERAPY

Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship

(2012) Dror Marchaim et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae

(2012) Asako Doi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum  -lactamases: a systematic review and meta-analysis

(2012) K. Z. Vardakas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality

(2011) Hsing-Chun Chung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Optimizing Antimicrobial Therapy in Sepsis and Septic Shock

(2009) Anand Kumar   CRITICAL CARE CLINICS

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION